Related Experiment Video
Updated: May 9, 2025

Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells
Published on: March 3, 2015
Representation Meets Optimization: Training PINNs and PIKANs for Gray-Box Discovery in Systems Pharmacology
Nazanin Ahmadi Daryakenari1, Khemraj Shukla2, George Em Karniadakis2
1Center for Biomedical Engineering, Brown University, Providence, 02912, RI, USA.
Physics-Informed Kolmogorov-Arnold Networks (PIKANs) offer an alternative to Physics-Informed Neural Networks (PINNs) for system identification. This study benchmarks PIKANs and PINNs, providing guidance for optimizing their performance in systems pharmacology.
Area of Science:
- Computational Science
- Biomedical Engineering
- Machine Learning
Background:
- Physics-Informed Neural Networks (PINNs) and Physics-Informed Kolmogorov-Arnold Networks (PIKANs) are advanced models for inverse problems and system identification.
- A comprehensive understanding of PIKANs' and PINNs' performance regarding accuracy and speed is lacking.
- Existing research has not fully explored the impact of optimizers and architectural choices on these models.
Purpose of the Study:
- To systematically investigate the influence of optimizers, representations, and training configurations on the performance of PINNs and PIKANs.
- To introduce and evaluate a modified PIKAN architecture, tanh-cPIKAN, for enhanced performance.
- To provide practical guidance for selecting optimal models and training strategies in systems pharmacology.
Main Methods:
- Benchmarking a wide array of optimizers (first-order, second-order, hybrid) and learning rate schedulers using the Optax library.
- Evaluating the impact of model architecture (MLP vs. KAN), numerical precision (single vs. double), and warm-up phases.
- Assessing optimizer scalability for larger models and analyzing JAX-related trade-offs in computational efficiency and numerical accuracy.
- Utilizing two systems pharmacology case studies: a pharmacokinetics model and a chemotherapy drug-response model.
Main Results:
- Identified effective optimizer and representation combinations for learning gray-box models under challenging conditions (ill-posed, non-unique, data-sparse).
- Demonstrated the performance variations influenced by model architecture, numerical precision, and initial learning rates.
- Quantified the trade-offs associated with JAX implementation regarding computational speed and accuracy.
- The tanh-cPIKAN architecture showed promise for enhanced performance.
Conclusions:
- The study offers practical insights into selecting appropriate optimizers and architectures for robust and efficient gray-box discovery in systems pharmacology.
- Findings provide actionable guidance for improving the training of physics-informed networks in biomedical applications.
- Optimizing training configurations is crucial for maximizing the accuracy and speed of PIKANs and PINNs.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Protein-protein Interfaces
Drug Discovery: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Mechanistic Models: Overview of Compartment Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data